Wastewater epidemiology is an important tool in the fight against COVID-19, allowing for rapid, non-invasive insight into the health of large or targeted populations and identifying community risk up to 7-days before clinical testing. LuminUltra has developed the first complete, rapid, and on-site COVID-19 wastewater testing solution — making community health assessment accessible to both the public and private sector around the world.

The GeneCount® SARS-CoV-2 Wastewater Test Kit extracts SARS-CoV-2 RNA directly from a 1 mL sample of raw wastewater using magnetic binding bead technology, removing the need to pre-concentrate samples. This ground-breaking solution allows for simultaneous testing of both the liquid and solids fraction of the wastewater, increasing the accuracy of the result.

Reducing the time from sample collection to result is crucial in achieving the greatest benefit of wastewater testing — early detection. LuminUltra’s solution can test multiple samples on-site in approximately 2 hours, making the process more efficient and therefore available at a lower price point than other wastewater testing solutions.

Visit luminultra.com to learn more.